Shampa Das

Has grant

Professor

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Expansion of assessment of pharmacodynamics of flomoxef-fosfomycin and fosfomycin-amikacin combinations for neonatal sepsis using the HIFM

Open Date: 2022-08-01

Close Date: 2024-01-01

Grant: Close

Expanding the antibiotic spectrum of novel teixobactins to target multi-drug resistant Gram-negative bacteria

Open Date: 2022-08-01

Close Date: 2025-01-01

Grant: Close

PIPE-CF: An evidence-based preclinical framework for the development of antimicrobial therapeutics in cystic fibrosis

Open Date: 2021-10-01

Close Date: 2025-08-01

Grant: Close

Population PK analysis of SPR206 and PTA simulation to support selection of clinical dose regimens

Open Date: 2021-09-01

Close Date: 2023-07-01

Grant: Close

PK-PD assessment of BV100 in the hollow fibre infection model

Open Date: 2021-04-01

Close Date: 2024-02-01

Articles (10)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Alasdair MacGowan

Consultant in Infection/Professor of Antimicrobial Therapeutics

North Bristol NHS Trust

UNITED KINGDOM

View details

Fernando Docobo-Pérez

Universidad de Málaga Facultad de Medicina

SPAIN

View details

Francois Franceschi

Head

SWITZERLAND

View details

Laura Piddock

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shampa Das

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing

Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance

Pharmacodynamics of Meropenem and Tobramycin for Neonatal Meningoencephalitis: Novel Approaches to Facilitate the Development of New Agents to Address the Challenge of Antimicrobial Resistance

Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance

Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria

Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models

Reply to Asempa et al., “The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models”

Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia

Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility

Pharmacodynamics of the Novel Metallo-β-Lactamase Inhibitor ANT2681 in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae

Collaborators (4)

Alasdair MacGowan

Fernando Docobo-Pérez

Francois Franceschi

Laura Piddock

Make your next move.